{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicmp2s2ik4v5equf4m6isuqssqct65mr7mkt2eni4css46az5rlqy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhfcnnnrquw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieylr3bxxjxp7etw72mk5amt63siinkk3q5xvkwq5xeayz2vxyhai"
    },
    "mimeType": "image/jpeg",
    "size": 45719
  },
  "path": "/2026/03/18/huntingtons-uniqure-fda-jnj-psoriasis-icotyde-readout-newsletter/?utm_campaign=rss",
  "publishedAt": "2026-03-18T15:03:28.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research",
    "STAT+"
  ],
  "textContent": "A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter.",
  "title": "STAT+: A Huntington’s researcher on the UniQure-FDA fray",
  "updatedAt": "2026-03-18T15:03:31.000Z"
}